Global X Genomics & Biotechnology UCITS ETF USD Acc | GNOMRegistrer dig for at låse op for ratings |
Fondens performance | 30-04-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | - | - | -33,1 | -8,8 | -12,9 | |
+/-Kat | - | - | -23,3 | -8,2 | -16,3 | |
+/-Indeks | - | - | -33,2 | -8,8 | -19,2 | |
Kategori: Sektor - Sundhed, Aktier | ||||||
Kategoribenchmark: Morningstar Gbl Health TME ... |
Oversigt | ||
Closing Price 14-05-2024 | USD 7,65 | |
Kursændring 1 dag | 1,52% | |
Morningstar Kategori™ | Sektor - Sundhed, Aktier | |
Omsætning | 7039 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BM8R0N95 | |
Markedsværdi i alt (mio.) 30-09-2022 | USD 6,35 | |
Seneste TNA(mio.) 14-05-2024 | USD 6,78 | |
Løbende omkostning 12-01-2024 | 0,50% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: Global X Genomics & Biotechnology UCITS ETF USD Acc | GNOM |
The investment objective of the Fund is to provide investment results that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the “Index”). |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
- - | ||
Startdato 02-11-2021 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
Solactive Genomics v2 USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Formuefordeling Global X Genomics & Biotechnology UCITS ETF USD Acc | GNOM | 13-05-2024 |
|
|
Top 5 placeringer | Sektor | % |
Bio-Techne Corp | Healthcare | 4,87 |
Intellia Therapeutics Inc | Healthcare | 4,46 |
Moderna Inc | Healthcare | 4,35 |
Natera Inc | Healthcare | 4,26 |
Agilent Technologies Inc | Healthcare | 4,05 |
Øget Mindsket Ny siden sidste portefølje | ||
Global X Genomics & Biotechnology UCITS ETF USD Acc | GNOM |